布鲁顿酪氨酸激酶及其抑制剂研究进展(6)
[32] Treon SP， Tripsas CK， Meid K， et al. Ibrutinib in previously treated Waldenstr？m’s macroglobulinemia [J]. N Engl J Med， 2015， 372(15)： 1430-1440.[33] Byrd JC， Brown JR， O’Brien S， et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia[J]. N Engl J Med， 2014， 371(3)： 213-223.
[34] Coutré SE， Furman RR， Flinn IW， et al. Extended treatment with single-agent ibrutinib at the 420 mg dose leads to durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma [J]. Clin Cancer Res ......
您现在查看是摘要页，全文长 3482 字符。